E-Cigarettes: Harmful or Harm-Reducing?

Tuesday, January 17, 2017, 12:00 AM - Tuesday, April 14, 2020, 11:59 PM PST, Online Course

Internet Enduring Material Sponsored by the Stanford University School of Medicine. Presented by Stanford Prevention Research Center and the Department of Otolaryngology-Head & Neck Surgery at Stanford University School of Medicine

This CME activity focuses on the science of e-cigarettes – particularly health risks and benefits. Based on observed patterns in questions from real patients and answers from practicing physicians, we emphasize potential health impacts of e-cigarettes and regulated alternatives such as nicotine replacement therapy. Opportunities focus on special issues related to youth and use by patients in perioperative phase, cancer treatment or cardiovascular disease treatment. Online learners are engaged through interactive video role-play, expert interviews, and interactive activities.

Intended Audience

This course is designed for physicians in cardiology, family practice, primary care, general surgery, internal medicine, oncology, pediatrics, psychiatry, obstetrics and gynecology, and nurse practitioners, physician assistants, nurses, clinical psychologists, tobacco treatment specialists (TTS) as well as other licensed addiction treatment providers.

  Release Date: January 17, 2017
  Latest Review Date: June 15, 2018
  Expiration Date: April 14, 2020
  Estimated Time to Complete: 1.50 hours
  CME Credits Offered: 1.50
  Registration Fee: FREE

AMA PRA Category 1 Credits™ (1.50 hours), Non-Physician Participation Credit (1.50 hours)

1. Investigate new information about e-cigarette risks and benefits.
2. Evaluate the quality of e-cigarette information and interpret risks and benefits of e-cigarettes based on scientific evidence.
3. Evaluate the quality of e-cigarette information and interpret risks and benefits of e-cigarettes based on scientific evidence. Develop informed professional opinions about when to warn against or recommend e-cigarettes.
4. Assess e-cigarette use in all patients who currently use tobacco.
5. Apply evidence-based brief tobacco/nicotine cessation counseling (5’As Ask-Advise-Assess-Assist-Arrange) protocol in instances where patients ask about e-cigarettes.
6. Counsel patients who are using or considering using e-cigarettes to attempt cessation with FDA-approved nicotine replacement therapy (NRT) or pharmacotherapy.

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Stanford University School of Medicine designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The California Board of Registered Nursing recognizes that Continuing Medical Education (CME) is acceptable for meeting RN continuing education requirements as long as the course is certified for AMA PRA Category 1 Credit™ (rn.ca.gov). Nurses will receive a Certificate of Participation following this activity that may be used for license renewal.
 

Cultural and Linguistic Competency

The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: http://lane.stanford.edu/portals/cultural.html

Bibliography

Al-Abed, A., Chung, T., Ismail, I., Lin, E., Sergakis, G., & Mays, M. (2014). Knowledge, perceptions, and awareness of electronic cigarettes among healthcare providers and in-patients (abstract 2022379). Respiratory Care, 59 (10), OF45.

Allem, J.-P., Forster, M., Neiberger, A., & Unger, J. B. (2015). Characteristics of emerging adulthood and e-cigarette use: Findings from a pilot study. Addictive behaviors, 50, 40-44. doi: http://dx.doi.org/10.1016/j.addbeh.2015.06.023

Arrazola, R. A., Singh, T., Corey, C., Husten, C., Neff, L., Apelberg, B. J., Caraballo, R. S. (2015). Tobacco use among middle and high school students - United States, 2011-2014. MMWR Morb Mortal Wkly Rep., 64(14), 381-385.

For a complete list, please view the References/Bibliography page in the Course.

Disclosures

The following planner and speakers indicated having relevant relationship(s) with industry to disclose:

Judith Prochaska, PhD, MPH
Associate Professor of Medicine (Stanford Prevention Research Center)
Stanford University School of Medicine
Course Director
Speaker

Dr. Prochaska has indicated that she is on the advisory board, has contracted research, and serves as a consultant to Pfizer.

Maciej Goniewicz, PhD, PharmD
Assistant Professor of Oncology, Department of Health Behavior
Roswell Park Cancer Institute, Buffalo, NY
Speaker

Dr. Goniewicz has indicated that he is on an advisory board for Johnson & Johnson.

The following reviewer, planners, and speakers have indicated that they have no relationships with industry to disclose relative to the content of this activity:

Robert K. Jackler, MD
Edward C. and Amy H. Sewall Professor in Otorhinolaryngology
Professor, by Courtesy, of Neurosurgery and of Surgery 
Stanford University School of Medicine
Course Director
Content Reviewer
Speaker

Cati Brown-Johnson, PhD
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention
Stanford University School of Medicine
Course Director

Smita Das, MD, PhD, MPH
Clinical Instructor, Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Planner, Reviewer

Marily Oppezzo, MS, RD, PhD
Postdoctoral Research Fellow, SCRDP/ Heart Disease Prevention 
Stanford University School of Medicine
Planner

Suzaynn Schick, PhD
Professor, Division of Occupational & Environmental Medicine
University of California - San Fransisco School of Medicine
Speaker

Priya Fielding-Singh, PhD
Postdoctoral Research Fellow, Stanford Prevention Research Center
Stanford University School of Medicine
Author

Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology. A portion of this funding supports this activity.